{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:16:37Z","timestamp":1787318197507,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,7,18]],"date-time":"2021-07-18T00:00:00Z","timestamp":1626566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,18]],"date-time":"2021-07-18T00:00:00Z","timestamp":1626566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s42000-021-00309-y","type":"journal-article","created":{"date-parts":[[2021,7,18]],"date-time":"2021-07-18T00:02:20Z","timestamp":1626566540000},"page":"745-752","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Outcomes of transsphenoidal surgery in dopamine agonist-resistant prolactinomas: a retrospective study"],"prefix":"10.1007","volume":"20","author":[{"given":"Liguang","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xialin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,18]]},"reference":[{"issue":"2","key":"309_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3171\/jns.2002.97.2.0307","volume":"97","author":"AP Amar","year":"2002","unstructured":"Amar AP, Couldwell WT, Chen JC, Weiss MH (2002) Predictive value of serum prolactin levels measured immediately after transsphenoidal surgery. J Neurosurg 97(2):307\u2013314. https:\/\/doi.org\/10.3171\/jns.2002.97.2.0307","journal-title":"J Neurosurg"},{"issue":"3","key":"309_CR2","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s11102-010-0283-y","volume":"14","author":"M Babey","year":"2011","unstructured":"Babey M, Sahli R, Vajtai I et al (2011) Pituitary surgery for small prolactinomas as an alternative to treatment with dopamine agonists. Pituitary 14(3):222\u2013230. https:\/\/doi.org\/10.1007\/s11102-010-0283-y","journal-title":"Pituitary"},{"issue":"2","key":"309_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2019.101290","volume":"33","author":"P Chanson","year":"2019","unstructured":"Chanson P, Maiter D (2019) The epidemiology, diagnosis and treatment of Prolactinomas: the old and the new. Best Pract Res Clin Endocrinol Metab 33(2):101290. https:\/\/doi.org\/10.1016\/j.beem.2019.101290","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"309_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s10143-017-0818-z","volume":"40","author":"M Del Basso De Caro","year":"2017","unstructured":"Del Basso De Caro M, Solari D, Pagliuca F et al (2017) Atypical pituitary adenomas: clinical characteristics and role of ki-67 and p53 in prognostic and therapeutic evaluation. A series of 50 patients. Neurosurg Rev 40(1):105\u2013114. https:\/\/doi.org\/10.1007\/s10143-017-0818-z","journal-title":"Neurosurg Rev"},{"issue":"1","key":"309_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4158\/EP161446.OR","volume":"23","author":"D Donegan","year":"2017","unstructured":"Donegan D, Atkinson JL, Jentoft M et al (2017) Surgical outcomes of prolactinomas in recent era: results of a heterogenous group. Endocr Pract 23(1):37\u201345. https:\/\/doi.org\/10.4158\/EP161446.OR","journal-title":"Endocr Pract"},{"issue":"5","key":"309_CR6","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1210\/er.2005-9998","volume":"27","author":"MP Gillam","year":"2006","unstructured":"Gillam MP, Molitch ME, Lombardi G, Colao A (2006) Advances in the treatment of prolactinomas. Endocr Rev 27(5):485\u2013534. https:\/\/doi.org\/10.1210\/er.2005-9998","journal-title":"Endocr Rev"},{"key":"309_CR7","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3389\/fendo.2020.00439","volume":"11","author":"G Zielinski","year":"2020","unstructured":"Zielinski G, Ozdarski M, Maksymowicz M et al (2020) Prolactinomas: prognostic factors of early remission after transsphenoidal surgery. Front Endocrinol (Lausanne) 11:439. https:\/\/doi.org\/10.3389\/fendo.2020.00439","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"309_CR8","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ecl.2014.11.003","volume":"44","author":"A Glezer","year":"2015","unstructured":"Glezer A, Bronstein MD (2015) Prolactinomas. Endocrinol Metab Clin North Am 44(1):71\u201378. https:\/\/doi.org\/10.1016\/j.ecl.2014.11.003","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"6","key":"309_CR9","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1007\/s00701-019-03879-4","volume":"161","author":"F Grimm","year":"2019","unstructured":"Grimm F, Maurus R, Beschorner R et al (2019) Ki-67 labeling index and expression of p53 are non-predictive for invasiveness and tumor size in functional and nonfunctional pituitary adenomas. Acta Neurochir (Wien) 161(6):1149\u20131156. https:\/\/doi.org\/10.1007\/s00701-019-03879-4","journal-title":"Acta Neurochir (Wien)"},{"issue":"45","key":"309_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013198","volume":"97","author":"YL Han","year":"2018","unstructured":"Han YL, Chen DM, Zhang C et al (2018) Retrospective analysis of 52 patients with prolactinomas following endoscopic endonasal transsphenoidal surgery. Medicine (Baltimore) 97(45):e13198. https:\/\/doi.org\/10.1097\/MD.0000000000013198","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"309_CR11","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1227\/00006123-199310000-00008","volume":"33","author":"E Knosp","year":"1993","unstructured":"Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33(4):610\u2013618. https:\/\/doi.org\/10.1227\/00006123-199310000-00008","journal-title":"Neurosurgery"},{"issue":"1","key":"309_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1530\/EJE-07-0248","volume":"158","author":"J Kreutzer","year":"2008","unstructured":"Kreutzer J, Buslei R, Wallaschofski H et al (2008) Operative treatment of prolactinomas: indications and results in a current consecutive series of 212 patients. Eur J Endocrinol 158(1):11\u201318. https:\/\/doi.org\/10.1530\/EJE-07-0248","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"309_CR13","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1530\/EJE-11-1000","volume":"166","author":"V Primeau","year":"2012","unstructured":"Primeau V, Raftopoulos C, Maiter D (2012) Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients. Eur J Endocrinol 166(5):779\u2013786. https:\/\/doi.org\/10.1530\/EJE-11-1000","journal-title":"Eur J Endocrinol"},{"key":"309_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2019.11.JNS192457","volume":"31","author":"MM Gerges","year":"2020","unstructured":"Gerges MM, Rumalla K, Godil SS et al (2020) Long-term outcomes after endoscopic endonasal surgery for nonfunctioning pituitary macroadenomas. J Neurosurg 31:1\u201312. https:\/\/doi.org\/10.3171\/2019.11.JNS192457","journal-title":"J Neurosurg"},{"issue":"1","key":"309_CR15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11102-019-00989-1","volume":"23","author":"P Souteiro","year":"2020","unstructured":"Souteiro P, Belo S, Carvalho D (2020) Dopamine agonists in prolactinomas: when to withdraw? Pituitary 23(1):8\u201344. https:\/\/doi.org\/10.1007\/s11102-019-00989-1","journal-title":"Pituitary"},{"issue":"Supplement","key":"309_CR16","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.4103\/0028-3886.287668","volume":"68","author":"MK Panigrahi","year":"2020","unstructured":"Panigrahi MK, Chandrasekhar YBVK (2020) Vooturi S (2020) Current status of surgery in management of prolactinomas. Neurol India 68(Supplement):S39\u2013S43. https:\/\/doi.org\/10.4103\/0028-3886.287668","journal-title":"Neurol India"},{"issue":"1","key":"309_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000499694","volume":"109","author":"L Vilar","year":"2019","unstructured":"Vilar L, Vilar CF, Lyra R, Freitas MDC (2019) Pitfalls in the diagnostic evaluation of hyperprolactinemia. Neuroendocrinology 109(1):7\u201319. https:\/\/doi.org\/10.1159\/000499694","journal-title":"Neuroendocrinology"},{"issue":"1","key":"309_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11102-005-5086-1","volume":"8","author":"DK Hamilton","year":"2005","unstructured":"Hamilton DK, Vance ML, Boulos PT, Laws ER (2005) Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists. Pituitary 8(1):53\u201360. https:\/\/doi.org\/10.1007\/s11102-005-5086-1","journal-title":"Pituitary"},{"issue":"11","key":"309_CR19","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.jocn.2015.06.001","volume":"22","author":"TR Smith","year":"2015","unstructured":"Smith TR, Hulou MM, Huang KT et al (2015) Current indications for the surgical treatment of prolactinomas. J Clin Neurosci 22(11):1785\u20131791. https:\/\/doi.org\/10.1016\/j.jocn.2015.06.001","journal-title":"J Clin Neurosci"},{"issue":"5","key":"309_CR20","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.3171\/2010.11.JNS101369","volume":"114","author":"MC Oh","year":"2011","unstructured":"Oh MC, Aghi MK (2011) Dopamine agonist-resistant prolactinomas. J Neurosurg 114(5):1369\u20131379. https:\/\/doi.org\/10.3171\/2010.11.JNS101369","journal-title":"J Neurosurg"},{"issue":"4","key":"309_CR21","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1210\/jc.2009-1191","volume":"95","author":"G Raverot","year":"2010","unstructured":"Raverot G, Wierinckx A, Dantony E et al (2010) Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up. J Clin Endocrinol Metab 95(4):1708\u20131716. https:\/\/doi.org\/10.1210\/jc.2009-1191","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"309_CR22","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/00006123-199902000-00006","volume":"44","author":"JB Tyrrell","year":"1999","unstructured":"Tyrrell JB, Lamborn KR, Hannegan LT et al (1999) Transsphenoidal microsurgical therapy of prolactinomas: initial outcomes and long-term results. Neurosurgery 44(2):254\u2013263. https:\/\/doi.org\/10.1097\/00006123-199902000-00006","journal-title":"Neurosurgery"},{"issue":"1","key":"309_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000495775","volume":"109","author":"D Maiter","year":"2019","unstructured":"Maiter D (2019) Management of dopamine agonist-resistant prolactinoma. Neuroendocrinology 109(1):42\u201350. https:\/\/doi.org\/10.1159\/000495775","journal-title":"Neuroendocrinology"},{"issue":"4","key":"309_CR24","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.nec.2019.05.010","volume":"30","author":"DA Donoho","year":"2019","unstructured":"Donoho DA, Laws ER Jr (2019) The role of surgery in the management of prolactinomas. Neurosurg Clin N Am 30(4):509\u2013514. https:\/\/doi.org\/10.1016\/j.nec.2019.05.010","journal-title":"Neurosurg Clin N Am"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-021-00309-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-021-00309-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-021-00309-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T13:47:05Z","timestamp":1636984025000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-021-00309-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,18]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["309"],"URL":"https:\/\/doi.org\/10.1007\/s42000-021-00309-y","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,18]]},"assertion":[{"value":"22 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Ethics Committee of the Second People\u2019s Hospital of Qinzhou.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was signed by all patients or their guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}